SCHEMBL23766673

SCHEMBL23766673

CC(C)OC(=O)NC(C)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.43
TSHR P16473 1/20 0.40
RAB9A P51151 2/20 0.38
MME P08473 2/20 0.38
ACE P12821 1/20 0.38
CPA1 P15085 1/20 0.38
ACE2 Q9BYF1 1/20 0.38
HCAR2 Q8TDS4 1/20 0.37
ALOX15 P16050 1/20 0.37
TYR P14679 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36
FOLH1 Q04609 6/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12658356 0.92 MME (0.42) HTTTSHRRAB9AMMEACE
SCHEMBL5501265 0.84 ALDH1A1 (0.39) TSHRRAB9AMMEACECPA1
SCHEMBL4745432 0.82 CTSS (0.39) HTTMMEACECPA1ACE2
SCHEMBL28101354 0.82 MME (0.36) HTTTSHRRAB9AMMEACE
SCHEMBL15271430 0.82 MME (0.36) HTTTSHRRAB9AMMEACE
SCHEMBL13127976 0.81 TSHR (0.46) HTTTSHRRAB9AHCAR2ALOX15
SCHEMBL13785218 0.81 ALOX15 (0.40) HTTTSHRRAB9AHCAR2ALOX15
SCHEMBL194100 0.80 MME (0.41) TSHRRAB9AMMEACECPA1
SCHEMBL444915 0.80 MME (0.41) TSHRRAB9AMMEACECPA1
SCHEMBL194101 0.80 MME (0.41) TSHRRAB9AMMEACECPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024043313-A1 REVERSIBLE THERMOCHROMIC COMPOSITION, MICROENCAPSULATED PIGMENT USING SAID REVERSIBLE THERMOCHROMIC COMPOSITION, WRITING TOOL, AND TOY 三菱ケミカル株式会社 2024-02-29 WO disclosed
US-11827586-B2 Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-11-28 US disclosed
US-11827586-B2 Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-11-28 US disclosed
US-20210253517-A1 METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253517-A1 METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF SLC6A15, SLC6A19, ALAD HTT 3462/4885TSHR 3390/4885RAB9A 1115/4885
US-11827586-B2 Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof SLC6A15, SLC6A19, ALAD HTT 3462/4885TSHR 3390/4885RAB9A 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.